Yüklüyor......
Biologics in asthma management – Are we out of breath yet?
The biologics authorized for the add-on therapy of severe asthma are monoclonal antibodies (mAbs). Before they are considered for therapy intensification, the patient’s asthma endotype is determined on the basis of phenotypic characteristics. So far, 5 biologics are available that target the signali...
Kaydedildi:
| Yayımlandı: | Allergol Select |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dustri-Verlag Dr. Karl Feistle
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7890935/ https://ncbi.nlm.nih.gov/pubmed/33615123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/ALX02192E |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|